Epsilon amino-caproic acid and tranexamic acid in the prevention of early recurrence of subarachnoid haemorrhage

Completed

Phase N/A Results

Summary of Purpose

To assess the relative efficacies of epsilon amino-caproic acid and tranexamic acid in reducing early recurrence of subarachnoid hemorrhage (SAH).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 April 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Comparative, controlled trial of 151 patients.

Contacts

Not available